NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
8 hedge funds and large institutions have $5.93K invested in NRX Pharmaceuticals Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
1.01% more ownership
Funds ownership: 0.12% → 1.13% (+1%)
11% less capital invested
Capital invested by funds: $6.65K → $5.93K (-$719)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$1.28K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$37 |
| 3 |
JFGIW
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$607 |
| 2 |
VF
Virtu Financial
New York
|
-$486 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $2K | -$486 | -6,595 | -16% |
|
2
Truist Financial
Charlotte,
North Carolina
| $1.75K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $783 | +$1.28K | +17,400 | New |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $692 | +$37 | +500 | +3% |
|
|
5
UBS Group
Zurich,
Switzerland
| $686 | -$607 | -8,230 | -35% |
|
|
JFGIW
6
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
| $15 | +$23 | +315 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $4 | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1 | – | – | – |
|
NRXPW Hedge Fund Activity: Q3 2024 in Review
8 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q3 2024, worth a combined $5.93K — down 11% from $6.65K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NRXPW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $1.28K. The largest seller was UBS Group, cutting an estimated $607.
- 8 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q3 2024, up from 6 in Q2 2024.
- Funds reported $5.93K of NRX Pharmaceuticals Warrant stock for Q3 2024, down 11% quarter-over-quarter.
- 2 funds opened new NRX Pharmaceuticals Warrant positions in Q3 2024 and 0 closed out, a net change of +2 holders.
- The largest NRX Pharmaceuticals Warrant buyer in Q3 2024 was Two Sigma Securities, an estimated $1.28K added.
- The largest NRX Pharmaceuticals Warrant seller in Q3 2024 was UBS Group, an estimated $607 sold.
Based on aggregated 13F filings for Q3 2024.